Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2001 | 12-2000 | 09-2000 | 06-2000 | 03-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 227,900 | 206,600 | 210,900 | 224,200 | 206,400 |
| Marketable Securities | 2,000 | N/A | 9,600 | 14,500 | 56,000 |
| Receivables | 1,136,400 | 1,195,400 | 1,191,600 | 1,190,100 | 1,136,700 |
| Inventories | 700,700 | 686,600 | 744,700 | 751,000 | 776,200 |
| Other current assets | 279,300 | 258,600 | 203,800 | 219,200 | 257,000 |
| TOTAL | $2,346,300 | $2,347,200 | $2,360,600 | $2,399,000 | $2,432,300 |
| Non-Current Assets | |||||
| PPE Net | 2,452,200 | 2,528,300 | 4,216,000 | 4,211,200 | 4,172,200 |
| Other Non-Current Assets | 2,298,100 | 2,376,800 | 2,376,200 | 2,442,700 | 2,426,200 |
| TOTAL | $4,750,300 | $4,905,100 | $6,592,200 | $6,653,900 | $6,598,400 |
| Total Assets | $7,096,600 | $7,252,300 | $7,237,100 | $7,360,100 | $7,384,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 463,500 | 320,200 | 145,500 | 242,900 | 347,200 |
| Accounts payable and accrued liabilities | 669,400 | 738,900 | 680,400 | 724,600 | 673,100 |
| Accrued Expenses | N/A | N/A | 848,500 | 797,100 | 969,200 |
| TOTAL | $2,370,800 | $2,244,100 | $1,911,000 | $2,059,600 | $2,293,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,530,400 | 2,536,900 | 2,681,300 | 2,532,300 | 2,285,400 |
| Other Non-Current Liabilities | 629,800 | 555,900 | 553,700 | 665,900 | 699,500 |
| TOTAL | $3,582,500 | $3,540,100 | $3,751,300 | $3,660,500 | $3,437,900 |
| Total Liabilities | $5,953,300 | $5,784,200 | $5,662,300 | $5,720,100 | $5,731,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,122,110 | N/A | N/A | N/A | N/A |
| Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 4,982,900 | 4,893,700 | 4,706,100 | 4,522,000 | 4,269,000 |
| Other shareholders' equity | -1,681,200 | -1,614,500 | -1,203,500 | -1,176,700 | -1,126,500 |
| TOTAL | $1,143,300 | $1,468,100 | $1,574,800 | $1,640,000 | $1,652,400 |
| Total Liabilities And Equity | $7,096,600 | $7,252,300 | $7,237,100 | $7,360,100 | $7,384,000 |